Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Notch-inducing hydrogels reveal a perivascular switch of mesenchymal stem cell fate.

Blache U, Vallmajo-Martin Q, Horton ER, Guerrero J, Djonov V, Scherberich A, Erler JT, Martin I, Snedeker JG, Milleret V, Ehrbar M.

EMBO Rep. 2018 Jul 2. pii: e45964. doi: 10.15252/embr.201845964. [Epub ahead of print]

PMID:
29967223
2.

An In Vitro Bone Model to Investigate the Role of Triggering Receptor Expressed on Myeloid Cells-2 in Bone Homeostasis.

Rossi E, Mracsko E, Papadimitropoulos A, Allafi N, Reinhardt D, Mehrkens A, Martin I, Knuesel I, Scherberich A.

Tissue Eng Part C Methods. 2018 Jul;24(7):391-398. doi: 10.1089/ten.TEC.2018.0061.

PMID:
29897015
3.

Decoration of RGD-mimetic porous scaffolds with engineered and devitalized extracellular matrix for adipose tissue regeneration.

Rossi E, Guerrero J, Aprile P, Tocchio A, Kappos EA, Gerges I, Lenardi C, Martin I, Scherberich A.

Acta Biomater. 2018 Jun;73:154-166. doi: 10.1016/j.actbio.2018.04.039. Epub 2018 Apr 21.

PMID:
29684623
4.

Wet milling of large quantities of human excision adipose tissue for the isolation of stromal vascular fraction cells.

Menzi N, Osinga R, Todorov A, Schaefer DJ, Martin I, Scherberich A.

Cytotechnology. 2018 Apr;70(2):807-817. doi: 10.1007/s10616-018-0190-z. Epub 2018 Jan 17.

PMID:
29344745
5.

Contrast-Enhanced Microtomographic Characterisation of Vessels in Native Bone and Engineered Vascularised Grafts Using Ink-Gelatin Perfusion and Phosphotungstic Acid.

Sutter S, Todorov A, Ismail T, Haumer A, Fulco I, Schulz G, Scherberich A, Kaempfen A, Martin I, Schaefer DJ.

Contrast Media Mol Imaging. 2017 Apr 23;2017:4035160. doi: 10.1155/2017/4035160. eCollection 2017.

6.

Engineering of an angiogenic niche by perfusion culture of adipose-derived stromal vascular fraction cells.

Cerino G, Gaudiello E, Muraro MG, Eckstein F, Martin I, Scherberich A, Marsano A.

Sci Rep. 2017 Oct 27;7(1):14252. doi: 10.1038/s41598-017-13882-3.

7.

Engineered, axially-vascularized osteogenic grafts from human adipose-derived cells to treat avascular necrosis of bone in a rat model.

Ismail T, Osinga R, Todorov A Jr, Haumer A, Tchang LA, Epple C, Allafi N, Menzi N, Largo RD, Kaempfen A, Martin I, Schaefer DJ, Scherberich A.

Acta Biomater. 2017 Nov;63:236-245. doi: 10.1016/j.actbio.2017.09.003. Epub 2017 Sep 8.

PMID:
28893630
8.

Human Adipose Mesenchymal Cells Inhibit Melanocyte Differentiation and the Pigmentation of Human Skin via Increased Expression of TGF-β1.

Klar AS, Biedermann T, Michalak K, Michalczyk T, Meuli-Simmen C, Scherberich A, Meuli M, Reichmann E.

J Invest Dermatol. 2017 Dec;137(12):2560-2569. doi: 10.1016/j.jid.2017.06.027. Epub 2017 Jul 31.

PMID:
28774590
9.

Ectopic bone formation by aggregated mesenchymal stem cells from bone marrow and adipose tissue: A comparative study.

Fennema EM, Tchang LAH, Yuan H, van Blitterswijk CA, Martin I, Scherberich A, de Boer J.

J Tissue Eng Regen Med. 2018 Jan;12(1):e150-e158. doi: 10.1002/term.2453. Epub 2017 Aug 21.

PMID:
28485099
10.

Bimodal morphological analyses of native and engineered tissues.

Jalili-Firoozinezhad S, Martin I, Scherberich A.

Mater Sci Eng C Mater Biol Appl. 2017 Jul 1;76:543-550. doi: 10.1016/j.msec.2017.03.140. Epub 2017 Mar 18.

PMID:
28482562
11.

Monocytes Seeded on Engineered Hypertrophic Cartilage Do Not Enhance Endochondral Ossification Capacity.

Todorov A, Scotti C, Barbero A, Scherberich A, Papadimitropoulos A, Martin I.

Tissue Eng Part A. 2017 Jul;23(13-14):708-715. doi: 10.1089/ten.tea.2016.0553. Epub 2017 Mar 24.

PMID:
28338424
12.

Low osmolality and shear stress during liposuction impair cell viability in autologous fat grafting.

Ismail T, Bürgin J, Todorov A, Osinga R, Menzi N, Largo RD, Haug M, Martin I, Scherberich A, Schaefer DJ.

J Plast Reconstr Aesthet Surg. 2017 May;70(5):596-605. doi: 10.1016/j.bjps.2017.01.023. Epub 2017 Feb 17.

PMID:
28320625
13.

Extracellular matrix and α5β1 integrin signaling control the maintenance of bone formation capacity by human adipose-derived stromal cells.

Di Maggio N, Martella E, Frismantiene A, Resink TJ, Schreiner S, Lucarelli E, Jaquiery C, Schaefer DJ, Martin I, Scherberich A.

Sci Rep. 2017 Mar 14;7:44398. doi: 10.1038/srep44398.

14.

Implantation of Stromal Vascular Fraction Progenitors at Bone Fracture Sites: From a Rat Model to a First-in-Man Study.

Saxer F, Scherberich A, Todorov A, Studer P, Miot S, Schreiner S, Güven S, Tchang LA, Haug M, Heberer M, Schaefer DJ, Rikli D, Martin I, Jakob M.

Stem Cells. 2016 Dec;34(12):2956-2966. doi: 10.1002/stem.2478. Epub 2016 Sep 16.

15.

Fat-Derived Stromal Vascular Fraction Cells Enhance the Bone-Forming Capacity of Devitalized Engineered Hypertrophic Cartilage Matrix.

Todorov A, Kreutz M, Haumer A, Scotti C, Barbero A, Bourgine PE, Scherberich A, Jaquiery C, Martin I.

Stem Cells Transl Med. 2016 Dec;5(12):1684-1694. Epub 2016 Jul 26.

16.

Generation of a Bone Organ by Human Adipose-Derived Stromal Cells Through Endochondral Ossification.

Osinga R, Di Maggio N, Todorov A, Allafi N, Barbero A, Laurent F, Schaefer DJ, Martin I, Scherberich A.

Stem Cells Transl Med. 2016 Aug;5(8):1090-7. doi: 10.5966/sctm.2015-0256. Epub 2016 Jun 22.

17.

Pericyte plasticity - comparative investigation of the angiogenic and multilineage potential of pericytes from different human tissues.

Herrmann M, Bara JJ, Sprecher CM, Menzel U, Jalowiec JM, Osinga R, Scherberich A, Alini M, Verrier S.

Eur Cell Mater. 2016 Apr 10;31:236-49.

18.

Characterization of vasculogenic potential of human adipose-derived endothelial cells in a three-dimensional vascularized skin substitute.

Klar AS, Güven S, Zimoch J, Zapiórkowska NA, Biedermann T, Böttcher-Haberzeth S, Meuli-Simmen C, Martin I, Scherberich A, Reichmann E, Meuli M.

Pediatr Surg Int. 2016 Jan;32(1):17-27. doi: 10.1007/s00383-015-3808-7. Epub 2015 Nov 30.

PMID:
26621500
19.

Facile fabrication of egg white macroporous sponges for tissue regeneration.

Jalili-Firoozinezhad S, Rajabi-Zeleti S, Mohammadi P, Gaudiello E, Bonakdar S, Solati-Hashjin M, Marsano A, Aghdami N, Scherberich A, Baharvand H, Martin I.

Adv Healthc Mater. 2015 Oct 28;4(15):2281-90. doi: 10.1002/adhm.201500482. Epub 2015 Sep 16.

PMID:
26376116
20.

Peripheral Nerve Repair: Multimodal Comparison of the Long-Term Regenerative Potential of Adipose Tissue-Derived Cells in a Biodegradable Conduit.

Kappos EA, Engels PE, Tremp M, Meyer zu Schwabedissen M, di Summa P, Fischmann A, von Felten S, Scherberich A, Schaefer DJ, Kalbermatten DF.

Stem Cells Dev. 2015 Sep 15;24(18):2127-41. doi: 10.1089/scd.2014.0424. Epub 2015 Jul 2.

PMID:
26134465
21.

Pooled thrombin-activated platelet-rich plasma: a substitute for fetal bovine serum in the engineering of osteogenic/vasculogenic grafts.

Tchang LA, Pippenger BE, Todorov A Jr, Wolf F, Burger MG, Jaquiery C, Bieback K, Martin I, Schaefer DJ, Scherberich A.

J Tissue Eng Regen Med. 2017 May;11(5):1542-1552. doi: 10.1002/term.2054. Epub 2015 Jun 15.

PMID:
26076897
22.

Engraftment of Prevascularized, Tissue Engineered Constructs in a Novel Rabbit Segmental Bone Defect Model.

Kaempfen A, Todorov A, Güven S, Largo RD, Jaquiéry C, Scherberich A, Martin I, Schaefer DJ.

Int J Mol Sci. 2015 Jun 4;16(6):12616-30. doi: 10.3390/ijms160612616.

23.

Effects of intersyringe processing on adipose tissue and its cellular components: implications in autologous fat grafting.

Osinga R, Menzi NR, Tchang LA, Caviezel D, Kalbermatten DF, Martin I, Schaefer DJ, Scherberich A, Largo RD.

Plast Reconstr Surg. 2015 Jun;135(6):1618-28. doi: 10.1097/PRS.0000000000001288.

PMID:
26017597
24.

Transcriptional regulation of tenascin-W by TGF-beta signaling in the bone metastatic niche of breast cancer cells.

Chiovaro F, Martina E, Bottos A, Scherberich A, Hynes NE, Chiquet-Ehrismann R.

Int J Cancer. 2015 Oct 15;137(8):1842-54. doi: 10.1002/ijc.29565. Epub 2015 Apr 29.

25.

Bone-forming capacity of adult human nasal chondrocytes.

Pippenger BE, Ventura M, Pelttari K, Feliciano S, Jaquiery C, Scherberich A, Walboomers XF, Barbero A, Martin I.

J Cell Mol Med. 2015 Jun;19(6):1390-9. doi: 10.1111/jcmm.12526. Epub 2015 Feb 16.

26.

Engineered decellularized matrices to instruct bone regeneration processes.

Papadimitropoulos A, Scotti C, Bourgine P, Scherberich A, Martin I.

Bone. 2015 Jan;70:66-72. doi: 10.1016/j.bone.2014.09.007. Epub 2014 Sep 28. Review.

PMID:
25260931
27.

Osteoblastic differentiation of Wharton jelly biopsy specimens and their mesenchymal stromal cells after serum-free culture.

Mueller AA, Forraz N, Gueven S, Atzeni G, Degoul O, Pagnon-Minot A, Hartmann D, Martin I, Scherberich A, McGuckin C.

Plast Reconstr Surg. 2014 Jul;134(1):59e-69e. doi: 10.1097/PRS.0000000000000305.

PMID:
25028857
28.

Tissue-engineered dermo-epidermal skin grafts prevascularized with adipose-derived cells.

Klar AS, Güven S, Biedermann T, Luginbühl J, Böttcher-Haberzeth S, Meuli-Simmen C, Meuli M, Martin I, Scherberich A, Reichmann E.

Biomaterials. 2014 Jun;35(19):5065-78. doi: 10.1016/j.biomaterials.2014.02.049. Epub 2014 Mar 27.

PMID:
24680190
29.

Combination of immortalization and inducible death strategies to generate a human mesenchymal stromal cell line with controlled survival.

Bourgine P, Le Magnen C, Pigeot S, Geurts J, Scherberich A, Martin I.

Stem Cell Res. 2014 Mar;12(2):584-98. doi: 10.1016/j.scr.2013.12.006. Epub 2013 Dec 27.

30.

Efficacy, safety and complications of autologous fat grafting to healthy breast tissue: a systematic review.

Largo RD, Tchang LA, Mele V, Scherberich A, Harder Y, Wettstein R, Schaefer DJ.

J Plast Reconstr Aesthet Surg. 2014 Apr;67(4):437-48. doi: 10.1016/j.bjps.2013.11.011. Epub 2013 Dec 12. Review.

PMID:
24394754
31.

The regeneration potential after human and autologous stem cell transplantation in a rat sciatic nerve injury model can be monitored by MRI.

Tremp M, Meyer Zu Schwabedissen M, Kappos EA, Engels PE, Fischmann A, Scherberich A, Schaefer DJ, Kalbermatten DF.

Cell Transplant. 2015;24(2):203-11. doi: 10.3727/096368913X676934. Epub 2013 Dec 30.

PMID:
24380629
32.

Non-adherent mesenchymal progenitors from adipose tissue stromal vascular fraction.

Mehrkens A, Di Maggio N, Gueven S, Schaefer D, Scherberich A, Banfi A, Martin I.

Tissue Eng Part A. 2014 Mar;20(5-6):1081-8. doi: 10.1089/ten.TEA.2013.0273. Epub 2013 Dec 11.

33.

Osteogenic graft vascularization and bone resorption by VEGF-expressing human mesenchymal progenitors.

Helmrich U, Di Maggio N, Güven S, Groppa E, Melly L, Largo RD, Heberer M, Martin I, Scherberich A, Banfi A.

Biomaterials. 2013 Jul;34(21):5025-35. doi: 10.1016/j.biomaterials.2013.03.040. Epub 2013 Apr 6.

PMID:
23566801
34.

mRNA transfection-based, feeder-free, induced pluripotent stem cells derived from adipose tissue of a 50-year-old patient.

Heng BC, Heinimann K, Miny P, Iezzi G, Glatz K, Scherberich A, Zulewski H, Fussenegger M.

Metab Eng. 2013 Jul;18:9-24. doi: 10.1016/j.ymben.2013.02.004. Epub 2013 Mar 28.

PMID:
23542141
35.

A familiar stranger: CD34 expression and putative functions in SVF cells of adipose tissue.

Scherberich A, Di Maggio ND, McNagny KM.

World J Stem Cells. 2013 Jan 26;5(1):1-8. doi: 10.4252/wjsc.v5.i1.1.

36.

Intraoperative engineering of osteogenic grafts combining freshly harvested, human adipose-derived cells and physiological doses of bone morphogenetic protein-2.

Mehrkens A, Saxer F, Güven S, Hoffmann W, Müller AM, Jakob M, Weber FE, Martin I, Scherberich A.

Eur Cell Mater. 2012 Sep 28;24:308-19.

37.

Perspective on the evolution of cell-based bone tissue engineering strategies.

Jakob M, Saxer F, Scotti C, Schreiner S, Studer P, Scherberich A, Heberer M, Martin I.

Eur Surg Res. 2012;49(1):1-7. doi: 10.1159/000338362. Epub 2012 Jul 11. Review.

38.

Enhancing the biological performance of synthetic polymeric materials by decoration with engineered, decellularized extracellular matrix.

Sadr N, Pippenger BE, Scherberich A, Wendt D, Mantero S, Martin I, Papadimitropoulos A.

Biomaterials. 2012 Jul;33(20):5085-93. doi: 10.1016/j.biomaterials.2012.03.082. Epub 2012 Apr 15.

PMID:
22510434
39.

Validation of an automated procedure to isolate human adipose tissue-derived cells by using the Sepax® technology.

Güven S, Karagianni M, Schwalbe M, Schreiner S, Farhadi J, Bula S, Bieback K, Martin I, Scherberich A.

Tissue Eng Part C Methods. 2012 Aug;18(8):575-82. doi: 10.1089/ten.TEC.2011.0617. Epub 2012 Apr 2.

40.

Generation of human adult mesenchymal stromal/stem cells expressing defined xenogenic vascular endothelial growth factor levels by optimized transduction and flow cytometry purification.

Helmrich U, Marsano A, Melly L, Wolff T, Christ L, Heberer M, Scherberich A, Martin I, Banfi A.

Tissue Eng Part C Methods. 2012 Apr;18(4):283-92. doi: 10.1089/ten.TEC.2011.0413. Epub 2011 Dec 19.

41.

Engineering of large osteogenic grafts with rapid engraftment capacity using mesenchymal and endothelial progenitors from human adipose tissue.

Güven S, Mehrkens A, Saxer F, Schaefer DJ, Martinetti R, Martin I, Scherberich A.

Biomaterials. 2011 Sep;32(25):5801-9. doi: 10.1016/j.biomaterials.2011.04.064. Epub 2011 May 24.

PMID:
21605897
42.

A 3D in vitro bone organ model using human progenitor cells.

Papadimitropoulos A, Scherberich A, Güven S, Theilgaard N, Crooijmans HJ, Santini F, Scheffler K, Zallone A, Martin I.

Eur Cell Mater. 2011 May 15;21:445-58; discussion 458.

43.

Fibroblast growth factor 2 and platelet-derived growth factor, but not platelet lysate, induce proliferation-dependent, functional class II major histocompatibility complex antigen in human mesenchymal stem cells.

Bocelli-Tyndall C, Zajac P, Di Maggio N, Trella E, Benvenuto F, Iezzi G, Scherberich A, Barbero A, Schaeren S, Pistoia V, Spagnoli G, Vukcevic M, Martin I, Tyndall A.

Arthritis Rheum. 2010 Dec;62(12):3815-25. doi: 10.1002/art.27736.

44.

Adipose tissue-derived progenitors for engineering osteogenic and vasculogenic grafts.

Scherberich A, Müller AM, Schäfer DJ, Banfi A, Martin I.

J Cell Physiol. 2010 Nov;225(2):348-53. doi: 10.1002/jcp.22313. Review.

PMID:
20626000
45.

Recapitulation of endochondral bone formation using human adult mesenchymal stem cells as a paradigm for developmental engineering.

Scotti C, Tonnarelli B, Papadimitropoulos A, Scherberich A, Schaeren S, Schauerte A, Lopez-Rios J, Zeller R, Barbero A, Martin I.

Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7251-6. doi: 10.1073/pnas.1000302107. Epub 2010 Apr 6.

46.

Towards an intraoperative engineering of osteogenic and vasculogenic grafts from the stromal vascular fraction of human adipose tissue.

Müller AM, Mehrkens A, Schäfer DJ, Jaquiery C, Güven S, Lehmicke M, Martinetti R, Farhadi I, Jakob M, Scherberich A, Martin I.

Eur Cell Mater. 2010 Mar 3;19:127-35.

47.

A novel three-dimensional culture system allows prolonged culture of functional human granulosa cells and mimics the ovarian environment.

Kossowska-Tomaszczuk K, Pelczar P, Güven S, Kowalski J, Volpi E, De Geyter C, Scherberich A.

Tissue Eng Part A. 2010 Jun;16(6):2063-73. doi: 10.1089/ten.TEA.2009.0684.

48.

The multipotency of luteinizing granulosa cells collected from mature ovarian follicles.

Kossowska-Tomaszczuk K, De Geyter C, De Geyter M, Martin I, Holzgreve W, Scherberich A, Zhang H.

Stem Cells. 2009 Jan;27(1):210-9. doi: 10.1634/stemcells.2008-0233.

49.

In vitro characterization of immune-related properties of human fetal bone cells for potential tissue engineering applications.

Montjovent MO, Bocelli-Tyndall C, Scaletta C, Scherberich A, Mark S, Martin I, Applegate LA, Pioletti DP.

Tissue Eng Part A. 2009 Jul;15(7):1523-32. doi: 10.1089/ten.tea.2008.0222.

PMID:
19196143
50.

Platelet lysate as a serum substitute for 2D static and 3D perfusion culture of stromal vascular fraction cells from human adipose tissue.

Müller AM, Davenport M, Verrier S, Droeser R, Alini M, Bocelli-Tyndall C, Schaefer DJ, Martin I, Scherberich A.

Tissue Eng Part A. 2009 Apr;15(4):869-75. doi: 10.1089/ten.tea.2008.0498.

PMID:
19191518

Supplemental Content

Loading ...
Support Center